Zetagen Therapeutics secures $10m to boost cancer treatment innovations

Zetagen Therapeutics, a biopharmaceutical firm specializing in advanced treatments for metastatic cancers, has successfully secured a substantial $9.79 million in its Series B funding round. ... Read More